Literature DB >> 6431621

Serogrouping of Neisseria gonorrhoeae: correlation of serogroup with disseminated gonococcal infection.

E G Sandström, J S Knapp, L B Reller, S E Thompson, E W Hook, K K Holmes.   

Abstract

Gonococci can be divided into serogroups WI, WII, and WIII by coagglutination. To assess the clinical correlation of serogroups of gonococci, we studied isolates of gonococci from patients with disseminated and uncomplicated gonococcal infections in three cities in the United States. Strains of Neisseria gonorrhoeae belonging to serogroup WI represented 85 (84%) of 101 isolates from patients with disseminated gonococcal infection (DGI) and 68 (40%) of 168 isolates from patients with uncomplicated gonorrhea (P less than .001). The auxotype Arg-, Hyx-, Ura- (AHU) represented 62 (61%) of 101 isolates from DGI and 54 (32%) of 168 isolates from uncomplicated infection (p less than .001); all AHU isolates were serogroup WI. Among other auxotypes, WI strains represented 25 (64%) of 39 isolates from patients with DGI and 14 (12%) of 114 from uncomplicated infections (P less than .001). In Atlanta only, 13 (34%) of 38 isolates from DGI were AHU, but 31 (82%) were serogroup WI (P less than .001). Thus gonococci of serogroup WI are associated with DGI in these cities of the United States, and this correlation appears to be independent of auxotype. Serogroup WI is correlated with serum resistance.

Entities:  

Mesh:

Year:  1984        PMID: 6431621     DOI: 10.1097/00007435-198404000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

1.  Experimental transmission of Neisseria gonorrhoeae from pregnant rat to fetus.

Authors:  S Nowicki; R Selvarangan; G Anderson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Serological classification in relation to auxotypes, plasmid contents, and susceptibilities to antimicrobials of PPNG and non-PPNG strains isolated in Greece.

Authors:  G Tzanakaki; L Mavrommati; E Tzelepi; S Kolyva; E Fragouli
Journal:  Genitourin Med       Date:  1989-06

Review 3.  Protein I: structure, function, and genetics.

Authors:  R C Judd
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 4.  Molecular epidemiology of gonorrhea.

Authors:  S K Sarafian; J S Knapp
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Genetic typing of the porin protein of Neisseria gonorrhoeae from clinical noncultured samples for strain characterization and identification of mixed gonococcal infections.

Authors:  Freyja Lynn; Marcia M Hobbs; Jonathan M Zenilman; Frieda M T F Behets; Kathleen Van Damme; Andry Rasamindrakotroka; Margaret C Bash
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Factor H facilitates adherence of Neisseria gonorrhoeae to complement receptor 3 on eukaryotic cells.

Authors:  Sarika Agarwal; Sanjay Ram; Jutamas Ngampasutadol; Sunita Gulati; Peter F Zipfel; Peter A Rice
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

7.  Molecular surveillance of clinical Neisseria gonorrhoeae isolates in Russia.

Authors:  Elena N Ilina; Nina Y Oparina; Egor A Shitikov; Alexandra D Borovskaya; Vadim M Govorun
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

8.  Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand.

Authors:  M S Brett; H G Davies; J R Blockley; H M Heffernan
Journal:  Genitourin Med       Date:  1992-10

9.  Evaluation of PorB variable region typing of Neisseria gonorrhoeae using PCR-ELISA in samples collected from men who have sex with men.

Authors:  A E Ling; M C Bash; F Lynn; N A Lister; P Zhu; S M Garland; C K Fairley; S N Tabrizi
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

10.  Innate recognition by neutrophil granulocytes differs between Neisseria gonorrhoeae strains causing local or disseminating infections.

Authors:  Alexandra Roth; Corinna Mattheis; Petra Muenzner; Magnus Unemo; Christof R Hauck
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.